Cannon Financial Strategists’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Hold |
4,141
| – | – | 0.12% | 52 |
|
|
2025
Q1 | $868K | Hold |
4,141
| – | – | 0.15% | 49 |
|
|
2024
Q4 | $736K | Buy |
4,141
+97
| +2% | +$17.2K | 0.13% | 51 |
|
|
2024
Q3 | $799K | Sell |
4,044
-63
| -2% | -$12.4K | 0.14% | 53 |
|
|
2024
Q2 | $704K | Hold |
4,107
| – | – | 0.13% | 48 |
|
|
2024
Q1 | $748K | Buy |
4,107
+100
| +2% | +$18.2K | 0.15% | 48 |
|
|
2023
Q4 | $621K | Hold |
4,007
| – | – | 0.13% | 50 |
|
|
2023
Q3 | $597K | Buy |
4,007
+63
| +2% | +$9.39K | 0.15% | 48 |
|
|
2023
Q2 | $531K | Hold |
3,944
| – | – | 0.15% | 55 |
|
|
2023
Q1 | $629K | Hold |
3,944
| – | – | 0.21% | 40 |
|
|
2022
Q4 | $637K | Hold |
3,944
| – | – | 0.23% | 38 |
|
|
2022
Q3 | $529K | Sell |
3,944
-212
| -5% | -$28.5K | 0.21% | 42 |
|
|
2022
Q2 | $637K | Buy |
4,156
+90
| +2% | +$13.8K | 0.25% | 41 |
|
|
2022
Q1 | $659K | Buy |
4,066
+156
| +4% | +$25.3K | 0.24% | 33 |
|
|
2021
Q4 | $529K | Hold |
3,910
| – | – | 0.19% | 44 |
|
|
2021
Q3 | $422K | Hold |
3,910
| – | – | 0.16% | 45 |
|
|
2021
Q2 | $440K | Hold |
3,910
| – | – | 0.17% | 42 |
|
|
2021
Q1 | $423K | Hold |
3,910
| – | – | 0.18% | 41 |
|
|
2020
Q4 | $419K | Sell |
3,910
-112
| -3% | -$12K | 0.2% | 39 |
|
|
2020
Q3 | $352K | Buy |
4,022
+112
| +3% | +$9.81K | 0.19% | 42 |
|
|
2020
Q2 | $384K | Hold |
3,910
| – | – | 0.23% | 37 |
|
|
2020
Q1 | $298K | Hold |
3,910
| – | – | 0.22% | 40 |
|
|
2019
Q4 | $346K | Hold |
3,910
| – | – | 0.23% | 38 |
|
|
2019
Q3 | $296K | Hold |
3,910
| – | – | 0.23% | 41 |
|
|
2019
Q2 | $284K | Hold |
3,910
| – | – | 0.24% | 37 |
|
|
2019
Q1 | $315K | Buy |
+3,910
| New | +$315K | 0.28% | 38 |
|